- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms of current therapies for diabetes mellitus type 2
Authors
Keywords
-
Journal
ADVANCES IN PHYSIOLOGY EDUCATION
Volume 36, Issue 4, Pages 275-283
Publisher
American Physiological Society
Online
2012-12-03
DOI
10.1152/advan.00094.2012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epac2: a sulfonylurea receptor?
- (2012) Holger Rehmann BIOCHEMICAL SOCIETY TRANSACTIONS
- Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study
- (2012) DIABETES CARE
- Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study
- (2012) Ronac Mamtani et al. JNCI-Journal of the National Cancer Institute
- Signal integration at the level of ion channel and exocytotic function in pancreatic β-cells
- (2011) Patrick E. MacDonald AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
- (2011) Yu Li et al. Cell Metabolism
- Direct Activation of Epac by Sulfonylurea Is Isoform Selective
- (2011) Katie J. Herbst et al. CHEMISTRY & BIOLOGY
- Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus
- (2011) Jens Juul Holst et al. CLINICAL DRUG INVESTIGATION
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
- (2011) Georgios S. Papaetis et al. CURRENT DRUG TARGETS
- Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
- (2011) R. A. DeFronzo DIABETES CARE
- Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
- (2011) J. D. Lewis et al. DIABETES CARE
- Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
- (2011) Y. Handelsman DIABETES CARE
- Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus
- (2011) R. R. Henry et al. DIABETES OBESITY & METABOLISM
- Treating diabetes today: a matter of selectivity of sulphonylureas
- (2011) S. Seino et al. DIABETES OBESITY & METABOLISM
- Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis
- (2011) K. R. Gerrald et al. DIABETES OBESITY & METABOLISM
- Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans
- (2011) B. Ahrén et al. DIABETES OBESITY & METABOLISM
- Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
- (2011) X. Stephenne et al. DIABETOLOGIA
- Glucagon-Like Peptide-1 Enhances Glucokinase Activity in Pancreatic β-Cells through the Association of Epac2 with Rim2 and Rab3A
- (2011) Jae-Hyung Park et al. ENDOCRINOLOGY
- Novel Biological Action of the Dipeptidylpeptidase-IV Inhibitor, Sitagliptin, as a Glucagon-Like Peptide-1 Secretagogue
- (2011) Ganesh V. Sangle et al. ENDOCRINOLOGY
- Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic β cells
- (2011) Colin A. Leech et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications
- (2010) Michael A. Nauck AMERICAN JOURNAL OF MEDICINE
- Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1
- (2010) Quan Shang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Advances in the Treatment of Type 2 Diabetes Mellitus
- (2010) Zafar H Israili AMERICAN JOURNAL OF THERAPEUTICS
- Pathogenesis of Fasting and Postprandial Hyperglycemia in Type 2 Diabetes: Implications for Therapy
- (2010) R. A. Rizza DIABETES
- Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
- (2010) J. M. Gaziano et al. DIABETES CARE
- An energetic tale of AMPK-independent effects of metformin
- (2010) Russell A. Miller et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- Incorporating Incretin-Based Therapies Into Clinical Practice: Differences Between Glucagon-Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors
- (2010) Jaime A. Davidson MAYO CLINIC PROCEEDINGS
- Adjunct therapy for type 1 diabetes mellitus
- (2010) Harold E. Lebovitz Nature Reviews Endocrinology
- Sulfonylurea action re-revisited
- (2010) Susumu Seino et al. Journal of Diabetes Investigation
- Efficacy and Safety of Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus
- (2009) Matthew P. Gilbert et al. AMERICAN JOURNAL OF MEDICINE
- Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
- (2009) Vivian A. Fonseca et al. DIABETES OBESITY & METABOLISM
- Regulation of insulin secretion: a matter of phase control and amplitude modulation
- (2009) J. C. Henquin DIABETOLOGIA
- The cAMP Sensor Epac2 Is a Direct Target of Antidiabetic Sulfonylurea Drugs
- (2009) C.-L. Zhang et al. SCIENCE
- Role of the cAMP sensor Epac as a determinant of KATPchannel ATP sensitivity in human pancreatic β-cells and rat INS-1 cells
- (2008) Guoxin Kang et al. JOURNAL OF PHYSIOLOGY-LONDON
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search